LPKAIN 5% CREAM (5 GR, 5 PACKS) – 2026 Price Turkey

by

Clinical Data Review: Comprehensive profile for LPKAIN 5% CREAM (5 GR, 5 PACKS), including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: LPKAIN 5% CREAM (5 GR, 5 PACKS)

Manufacturer: TAB PHARMACEUTICAL INDUSTRY INC.

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

LIDOKAIN
PRILOKAIN HIDROKLORUR 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

LPKAIN 5% CREAM (5 GR, 5 PACKS) is formulated with LIDOKAIN
PRILOKAIN HIDROKLORUR, a clinically established agent in medical practice.

  • Mechanism of Action: LIDOKAIN
    PRILOKAIN HIDROKLORUR acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to LIDOKAIN
    PRILOKAIN HIDROKLORUR     therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name LPKAIN 5% CREAM (5 GR, 5 PACKS)
Barcode (GTIN) 8680133000478
Generic Name LIDOKAIN
PRILOKAIN HIDROKLORUR
License Holder TAB PHARMACEUTICAL INDUSTRY INC.
Pharmacy Retail Price 1191.45 TL
⚠️ Clinical Safety Warning

Do not administer LPKAIN 5% CREAM (5 GR, 5 PACKS) if the patient has a known hypersensitivity or allergy to LIDOKAIN
PRILOKAIN HIDROKLORUR. Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.

Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via TAB PHARMACEUTICAL INDUSTRY INC..

Leave a Comment